Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.

Hughes T, Briercheck EL, Freud AG, Trotta R, McClory S, Scoville SD, Keller K, Deng Y, Cole J, Harrison N, Mao C, Zhang J, Benson DM, Yu J, Caligiuri MA.

Cell Rep. 2014 Jul 10;8(1):150-62. doi: 10.1016/j.celrep.2014.05.042. Epub 2014 Jun 19.

2.

Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells.

Ahn YO, Blazar BR, Miller JS, Verneris MR.

Blood. 2013 Mar 21;121(12):2234-43. doi: 10.1182/blood-2012-07-440099. Epub 2013 Jan 17.

3.

Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue.

Hughes T, Becknell B, Freud AG, McClory S, Briercheck E, Yu J, Mao C, Giovenzana C, Nuovo G, Wei L, Zhang X, Gavrilin MA, Wewers MD, Caligiuri MA.

Immunity. 2010 Jun 25;32(6):803-14. doi: 10.1016/j.immuni.2010.06.007.

4.

Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.

Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, Babic M, Paclik D, Stölzel K, Gröne J, Lozza L, Juelke K, Matzmohr N, Loiacono F, Petronelli F, Huntington ND, Moretta L, Mingari MC, Romagnani C.

Immunity. 2014 Dec 18;41(6):988-1000. doi: 10.1016/j.immuni.2014.11.010. Epub 2014 Nov 28.

5.

Effects of interleukin-15 on human CD3(-)CD117(+)CD56(-)OX40L(+) cell differentiation.

Kim S, Han S, Kim MY.

Hum Immunol. 2010 Aug;71(8):745-50. doi: 10.1016/j.humimm.2010.05.015. Epub 2010 May 25.

PMID:
20510321
6.

Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue.

Tang Q, Ahn YO, Southern P, Blazar BR, Miller JS, Verneris MR.

Blood. 2011 Apr 14;117(15):4052-5. doi: 10.1182/blood-2010-09-303081. Epub 2011 Feb 10.

7.

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M.

Nature. 2009 Feb 5;457(7230):722-5. doi: 10.1038/nature07537. Epub 2008 Nov 2.

8.

Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.

Hughes T, Becknell B, McClory S, Briercheck E, Freud AG, Zhang X, Mao H, Nuovo G, Yu J, Caligiuri MA.

Blood. 2009 Apr 23;113(17):4008-10. doi: 10.1182/blood-2008-12-192443. Epub 2009 Feb 24.

9.

Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.

Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, Saurat JH, Roosnek E, Chizzolini C.

Eur J Immunol. 2010 Sep;40(9):2450-9. doi: 10.1002/eji.201040461.

10.

Evidence for discrete stages of human natural killer cell differentiation in vivo.

Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, Caligiuri MA.

J Exp Med. 2006 Apr 17;203(4):1033-43. Epub 2006 Apr 10.

11.

G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.

Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M, Melenhorst J, Hensel N, Barrett AJ.

J Leukoc Biol. 2004 Dec;76(6):1214-9. Epub 2004 Sep 2.

PMID:
15345723
12.
13.

Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells.

Bonanno G, Mariotti A, Procoli A, Corallo M, Scambia G, Pierelli L, Rutella S.

BMC Immunol. 2009 Aug 27;10:46. doi: 10.1186/1471-2172-10-46.

14.

Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.

Montaldo E, Juelke K, Romagnani C.

Eur J Immunol. 2015 Aug;45(8):2171-82. doi: 10.1002/eji.201545598. Epub 2015 Jun 18. Review.

15.

IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.

Ambrosini P, Loiacono F, Conte R, Moretta L, Vitale C, Mingari MC.

Eur J Immunol. 2015 Jul;45(7):2061-71. doi: 10.1002/eji.201445326. Epub 2015 May 12. Erratum in: Eur J Immunol. 2015 Aug;45(8):2420.

16.

NKp80 Defines a Critical Step during Human Natural Killer Cell Development.

Freud AG, Keller KA, Scoville SD, Mundy-Bosse BL, Cheng S, Youssef Y, Hughes T, Zhang X, Mo X, Porcu P, Baiocchi RA, Yu J, Carson WE 3rd, Caligiuri MA.

Cell Rep. 2016 Jul 12;16(2):379-391. doi: 10.1016/j.celrep.2016.05.095. Epub 2016 Jun 30.

17.
18.

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA.

Blood. 2010 Jan 14;115(2):274-81. doi: 10.1182/blood-2009-04-215491. Epub 2009 Nov 6.

19.

Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.

Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B.

J Exp Med. 1996 Nov 1;184(5):1845-56. Erratum in: J Exp Med 1997 Mar 17;185(6):1150-1.

20.

Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.

Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjösberg JM, Spits H.

Nat Immunol. 2013 Mar;14(3):221-9. doi: 10.1038/ni.2534. Epub 2013 Jan 20.

PMID:
23334791

Supplemental Content

Support Center